Latest statistics and disclosures from ARCH Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KRTX, EQRX, ERAS, VERV, OMIC, and represent 99.67% of ARCH Venture Management's stock portfolio.
- Added to shares of these 6 stocks: KRTX (+$369M), EQRX (+$150M), ERAS (+$95M), VERV (+$57M), OMIC (+$24M), ZY.
- Started 6 new stock positions in ZY, VERV, OMIC, ERAS, KRTX, EQRX.
- Reduced shares in these 3 stocks: RUBY (-$13M), Chiasma (-$5.1M), SYRS.
- Sold out of its positions in Chiasma, SYRS.
- ARCH Venture Management was a net buyer of stock by $677M.
- ARCH Venture Management has $698M in assets under management (AUM), dropping by 3384.24%.
- Central Index Key (CIK): 0001274403
Tip: Access up to 7 years of quarterly data
Positions held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for ARCH Venture Management
Companies in the ARCH Venture Management portfolio as of the March 2022 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Karuna Therapeutics Ord (KRTX)||52.9||$369M||NEW||2.9M||126.79|
|Verve Therapeutics (VERV)||8.2||$57M||NEW||2.5M||22.82|
|Singular Genomics Systems In (OMIC)||3.4||$24M||NEW||3.8M||6.31|
|Rubius Therapeutics (RUBY)||0.3||$1.9M||-86%||350k||5.51|
Past Filings by ARCH Venture Management
SEC 13F filings are viewable for ARCH Venture Management going back to 2018
- ARCH Venture Management 2022 Q1 filed May 13, 2022
- Arch Venture Corp 2020 Q3 filed Nov. 16, 2020
- Arch Venture Corp 2020 Q2 filed Aug. 12, 2020
- Arch Venture Corp 2020 Q1 filed May 6, 2020
- Arch Venture Corp 2019 Q4 filed Feb. 5, 2020
- Arch Venture Corp 2019 Q3 filed Nov. 12, 2019
- Arch Venture Corp 2019 Q2 filed Aug. 9, 2019
- Arch Venture Corp 2018 Q4 amended filed May 17, 2019
- Arch Venture Corp 2019 Q1 filed May 14, 2019
- Arch Venture Corp 2018 Q4 filed Feb. 14, 2019